228 related articles for article (PubMed ID: 6186039)
1. Tumor induced immunosuppression.
Roth JA
Surg Gynecol Obstet; 1983 Feb; 156(2):233-40. PubMed ID: 6186039
[No Abstract] [Full Text] [Related]
2. [Immunological interrelationships of the body and the tumor].
Govallo VI
Vopr Onkol; 1975; 21(10):93-102. PubMed ID: 52944
[No Abstract] [Full Text] [Related]
3. Differential antigen presentation in tumor immunity.
Schatten S; Drebin JA; Granstein RD; Greene MI
Fed Proc; 1984 Jun; 43(9):2460-4. PubMed ID: 6327399
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide-sensitive and cyclophosphamide-resistant suppressor cells in the immune response to alloantigens.
Bonavida B; Hutchinson IV; Thomas A
Transplant Proc; 1979 Mar; 11(1):874-7. PubMed ID: 313108
[TBL] [Abstract][Full Text] [Related]
5. [Intercellular interactions in the immune response and their influencing].
Altunkova I
Vutr Boles; 1979; 18(5):9-15. PubMed ID: 390885
[No Abstract] [Full Text] [Related]
6. Mechanisms of tumor-induced immunological deficiencies and their possible significance in relation to the use of immunopotentiators in tumor-bearing hosts.
Kerbel RS
Biomedicine; 1974 Jul; 21(7):253-61. PubMed ID: 4547979
[No Abstract] [Full Text] [Related]
7. [Role of ascorbic acid in regulating immunological reactions].
Pletsityĭ KD
Vopr Pitan; 1979; (4):18-27. PubMed ID: 384669
[No Abstract] [Full Text] [Related]
8. Effects of anticancer drugs on the immune system in humans.
Ehrke MJ; Mihich E; Berd D; Mastrangelo MJ
Semin Oncol; 1989 Jun; 16(3):230-53. PubMed ID: 2658084
[No Abstract] [Full Text] [Related]
9. [Clinical immunology].
Hanson LA; Holm G; Perlmann P
Nord Med; 1974 Oct; 89(8):259-62. PubMed ID: 4549102
[No Abstract] [Full Text] [Related]
10. Effect of millimeter waves on cyclophosphamide induced suppression of the immune system.
Logani MK; Anga A; Szabo I; Agelan A; Irizarry AR; Ziskin MC
Bioelectromagnetics; 2002 Dec; 23(8):614-21. PubMed ID: 12395417
[TBL] [Abstract][Full Text] [Related]
11. [Depressive effect of hormones during pregnancy on cellular-type immunological reactions (a review of the literature)].
Ivanova LA; Trunova LA
Vopr Okhr Materin Det; 1978 May; 23(5):54-8. PubMed ID: 351951
[No Abstract] [Full Text] [Related]
12. [Clinical laboratory evaluation of the lymphocyte stimulation test in cancer (a review of the literature)].
Shats VIa
Lab Delo; 1974; 0(10):612-9. PubMed ID: 4139320
[No Abstract] [Full Text] [Related]
13. Chemical-induced immunomodulation.
Koller LD
J Am Vet Med Assoc; 1982 Nov; 181(10):1102-6. PubMed ID: 6816774
[No Abstract] [Full Text] [Related]
14. [Symposium on cancer and immunity. (2) Immunosuppressive factors in cancer-patients (author's transl)].
Urushizaki I
Nihon Naika Gakkai Zasshi; 1978 Dec; 67(12):1489-94. PubMed ID: 311371
[No Abstract] [Full Text] [Related]
15. [Introduction to the clinical use of immunosuppressive agents].
Bach JF
Ann Med Interne (Paris); 1974 Oct; 125(10):697-702. PubMed ID: 4548812
[No Abstract] [Full Text] [Related]
16. [Immune response inhibiting effect of blood serum in dermatoses].
Somos Z; Regényi B
Orv Hetil; 1975 Sep; 116(37):2184-6. PubMed ID: 52858
[No Abstract] [Full Text] [Related]
17. [Modification of the immune response by histamine in normal and immunodeficient patients (dysgammaglobulinemia with hyper IgM)].
Hébert J; Beaudoin R; Aubin M
Union Med Can; 1978 Apr; 107(4):371-5. PubMed ID: 306149
[No Abstract] [Full Text] [Related]
18. Antigen-specific suppressor ("blocking") factors in tumor immunity.
Hellström KE; Hellström I; Nelson K
Biomembranes; 1983; 11():365-88. PubMed ID: 6219721
[No Abstract] [Full Text] [Related]
19. [Methodological problems of screening immunotropic agents].
Uteshev BS
Farmakol Toksikol; 1984; 47(3):5-13. PubMed ID: 6610565
[TBL] [Abstract][Full Text] [Related]
20. [Influencing of the immunocytoadherence phenomenon by chemical immunosuppression in rats].
Hermann G; Sesterhenn K; Dostal G
Z Gesamte Exp Med Einschl Exp Chir; 1970; 153(1):59-73. PubMed ID: 5516384
[No Abstract] [Full Text] [Related]
[Next] [New Search]
